Oscar's Journey: From CSL Castoff to São Paulo Leader - Can He Rediscover His Spark?
Oscar's Disappointment in the Chinese Super League ...
Proficio Capital Partners LLC Buys Shares of 63,809 Carlisle Companies Incorporated (NYSE:CSL)
Proficio Capital Partners LLC bought a new position in shares of Carlisle Companies Incorporated (NYSE:CSL – Free Report) ...
Livewire Markets on MSN7d
Why CSL will likely underperform term deposits
Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s ...
3 Reasons to Sell CSL and 1 Stock to Buy Instead
Carlisle’s stock price fell to $343.26. Shareholders have lost 14.9% of their capital, which is disappointing considering the ...
Should you buy the dip on the CSL share price?
Has the market sell-off created an opportunity to buy this mega ASX 200 blue chip at an attractive price? The post Should you ...
CFC LDN: Why Chelsea are leaning on their London heritage with new branding
There is a good chance that UK-based football supporters know Chelsea is an area of London, so CFC LDN isn’t targeted at them ...
Are Sonic Healthcare or CSL shares a better buy?
Which of these healthcare giants is a better buy? The post Are Sonic Healthcare or CSL shares a better buy? appeared first on ...
In LA, cooking emissions rival fossil fuels as ozone pollution source
As the adoption of cleaner-burning engines and electric vehicles drives fossil fuel emissions lower, scientists have ...
Hoping to bag the boosted dividend from CSL shares? Here's your deadline…
CSL shares will pay a 9% higher interim dividend of US$1.30 per share on 9 April. Here's when the ASX healthcare giant will ...
BMW M Hybrid V8 Gets Special 50th Anniversary Livery for 12 Hours of Sebring
BMW North America is marking its 50th anniversary at the 73rd edition of the Twelve Hours of Sebring on March 15, with the ...
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...